Biologic manufacturing capacity expansion with single-use ...

10
Key variables to consider Biologic manufacturing capacity expansion with single-use technologies

Transcript of Biologic manufacturing capacity expansion with single-use ...

Page 1: Biologic manufacturing capacity expansion with single-use ...

Key variables to consider

Biologic manufacturing capacity expansion with single-use technologies

Page 2: Biologic manufacturing capacity expansion with single-use ...

The following presentation is based on a simulation of a 2 × 2000 L mAb process. The simulation compares a single-use process train (SU) with a comparable stainless steel-based process train (SS), both modeled in a traditional, stick-built facility. Are you interested in a simulation of your biomanufacturing process? With our range of simulation tools, we can assist in this, whether it is for scale up/down, “de-bottlenecking”, process intensification, transition from stainless to single use, or general optimization.

2

Page 3: Biologic manufacturing capacity expansion with single-use ...

Titer 3 g/L

Overall process yield 70%

Number of products per year 4

Facility utilization 80%

mAb output per year 168 kg

Assumptions: 70% recovery through purification of 20 batches per year, per reactor

Manufacturing setup simulation for 2 × 2000 L mAb process

TITER

2.0 3.0 4.0

2 × 500 L 28 42 56

2 × 1000 L 56 84 112

2 × 2000 L 112 168 224

4 × 2000 L 224 336 448

3

Page 4: Biologic manufacturing capacity expansion with single-use ...

Time to market and capital expenditure

CAPEX = capital expenditure

Single-use vs stainless steel technologies

Stainless steel technologies take longer to procure, source, qualify, and validate.

The initial cost is also higher.

Single-use technologies provide faster time to market at lower capital expenditure.

Time to market

9–12 monthsSU

SS 24 months

CAPEX

52%SU

SS 100%

4

Page 5: Biologic manufacturing capacity expansion with single-use ...

Operating expense

OPEX = operational expenditure

Single-use vs stainless steel technologies

Single-use technologies allowed 32% reduction in labor, based on elimination of cleaning and sanitization

in place (CIP, SIP), and related testing.

* Industry reports vary from 70% to 120%

SU

SS 100%

68%

OPEX — labor

SU

SS 100%

70% *

OPEX

5

Page 6: Biologic manufacturing capacity expansion with single-use ...

Changeover and outputSingle-use vs stainless steel technologies

Changeover

SU

SS 5–10 days

1–2 days

mAb_01: batch 1 mAb_01: batch 2 mAb_02: batch 12 DAYS

changeover

2 DAYS

changeover

Output

SU

SS 40 batches per year

44 batches per year

6

Page 7: Biologic manufacturing capacity expansion with single-use ...

FootprintSingle-use vs stainless steel technologies

MEDIA

CLEANUTILITIES

CLEANUTILITIES

WAREHOUSE

LOCKERSGOWNING

LABS

OFFICES

EQUIP.PREP.

CIP/SIP

WASH

INOC./PREP.

CELL CULTURE

PRE-VIRAL DSP

POST-VIRAL DSP

INOC./PREP.

CELL CULTURE

PRE-VIRAL DSP

POST-VIRAL DSP

BUFFERS MEDIA

PLANT/CLEANUTILITIES

WAREHOUSE

LOCKERSGOWNING

LABS

OFFICES

INOC./PREP.

CELL CULTURE

CELL CULTURE

PRE-VIRAL DSP

POST-VIRAL DSP

INOC./PREP.

PRE-VIRAL DSP

POST-VIRAL DSP

BUFFERS

Single-useSingle-use technologies enable smaller facility,

less cleanroom space — resulting in lower utilities and HVAC costs.

SU

SS 100%

70%

Footprint

HVAC = central heating ventilation and air-conditioning DSP = downstream processing Equip. prep. = equipment preparation Inoc./prep. = inoculation/preparation

MEDIA

CLEANUTILITIES

CLEANUTILITIES

WAREHOUSE

LOCKERSGOWNING

LABS

OFFICES

EQUIP.PREP.

CIP/SIP

WASH

INOC./PREP.

CELL CULTURE

PRE-VIRAL DSP

POST-VIRAL DSP

INOC./PREP.

CELL CULTURE

PRE-VIRAL DSP

POST-VIRAL DSP

BUFFERS MEDIA

PLANT/CLEANUTILITIES

WAREHOUSE

LOCKERSGOWNING

LABS

OFFICES

INOC./PREP.

CELL CULTURE

CELL CULTURE

PRE-VIRAL DSP

POST-VIRAL DSP

INOC./PREP.

PRE-VIRAL DSP

POST-VIRAL DSP

BUFFERS

Stainless steel

7

Page 8: Biologic manufacturing capacity expansion with single-use ...

Cytiva’s single-use technologies Across the entire bioprocess workflow

8

Page 9: Biologic manufacturing capacity expansion with single-use ...

NFF = normal flow filtration UF/DF = ultrafiltration/diafiltration CFF = crossflow filtration

Cell culture seed train

ReadyToProcess WAVE™ 25 system

Xcellerex XDR 200 L bioreactor

Xcellerex XDR 500 L bioreactor

Cell culture production

Xcellerex XDR 2000 L bioreactor

ReadyToProcess™ filter for CFF

Virus reduction

Xcellerex XDUO mixers

Harvest operations

FlexFactory™ harvest

BioProcess™ NFF Pump System

Buffer preparation: Xcellerex XDUO 100 to 2500 L mixers, HyClone buffers and process liquids

Medium preparation: Xcellerex™ XDUO 100 to 2500 L mixers, HyClone™ cell culture media

Purification operations

ÄKTA™ ready system

ReadyToProcess chromatography column

ReadyToProcess filter for CFF

Virus filtration

FlexFactory viral clearance

BioProcess NFF Pump System

Bulk formulation and sterile filtration

Bulk fill equipment

Fluid management

ReadyToProcess portfolio

ReadyCircuit™ bag and filter assemblies

ReadyToProcess bins and ReadyCircuit bags

ReadyMate™ aseptic connectors

Fast Trak Services

Process development

Bridge Manufacturing Services

Training and education

9

Page 10: Biologic manufacturing capacity expansion with single-use ...

cytiva.com/singleuseCytiva and the Drop logo are trademarks of Global Life Sciences IP Holdco LLC or an affiliate. ÄKTA, BioProcess, FlexFactory, HyClone, ReadyCircuit, ReadyMate, ReadyToProcess, ReadyToProcess WAVE, and Xcellerex are trademarks of Global Life Sciences Solutions USA LLC or an affiliate doing business as Cytiva.

© 2020 Cytiva

For local office contact information, visit cytiva.com/contact

CY14204-11Sep20-BR